𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of interferon-α-induced dendritic cells in the therapy of patients with malignant brain gliomas

✍ Scribed by O. Yu. Leplina; V. V. Stupak; Yu. P. Kozlov; I. V. Pendyurin; S. D. Nikonov; M. A. Tikhonova; N. V. Sycheva; A. A. Ostanin; E. R. Chernykh

Publisher
Springer US
Year
2007
Tongue
English
Weight
334 KB
Volume
143
Category
Article
ISSN
0007-4888

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pulmonary side effects of interferon-α t
Pulmonary side effects of interferon-α therapy in patients with hematological malignancies
✍ Patrik Anderson; Martin Höglund; Stig Rödjer 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 1 views

## Abstract Several side effects of interferon‐α‐2b (IFN‐α) therapy have been described. Pulmonary side effects have seldom been reported. The four patients we describe all developed respiratory disorders while being treated with IFN‐α for hematological malignancies. We point out the similarities a

Vaccination with tumor cell lysate-pulse
Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect of IFN-β gene therapy for malignant glioma in an experimental mouse intracranial glioma
✍ Ryuta Saito; Masaaki Mizuno; Norimoto Nakahara; Takaya Tsuno; Toshihiro Kumabe; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 372 KB 👁 1 views

## Abstract Interferon‐β (IFN‐β) has been used as an antitumor drug against human glioma, melanoma and medulloblastoma since the 1980s. Recently, we developed a new gene therapy using the __IFN__‐β gene against malignant gliomas and then began clinical trials in 2000. Since stimulation of immune sy

Involvement of dendritic cell frequency
Involvement of dendritic cell frequency and function in virological relapse in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients
✍ Ichiyo Itose; Tatsuya Kanto; Michiyo Inoue; Masanori Miyazaki; Hideki Miyatake; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

## Abstract A combination of pegylated interferon α (PEG‐IFNα) and ribavirin has been used widely. Enhancement of immune response against hepatitis C virus (HCV) is known to be involved in the efficacy of the combination therapy. The aim of the study was to elucidate whether the frequency or functi